CVE-2020-10554
CVE-2020-10554 is a high-severity vulnerability in Psyprax with a CVSS 3.x base score of 7.5. It is not currently listed as actively exploited by CISA, and its EPSS exploit-prediction score is low. The underlying weakness is classified as CWE-326.
Key facts
- Severity: High (CVSS 3.x base score 7.5)
- CVSS v2: 5.0
- EPSS exploit prediction: 1% (51st percentile)
- Actively exploited: Not listed in CISA KEV
- Weakness: CWE-326
- Affected product: Psyprax
- Published:
- Last modified:
Description
An issue was discovered in Psyprax beforee 3.2.2. Passwords used to encrypt the data are stored in the database in an obfuscated format, which can be easily reverted. For example, the password AAAAAAAA is stored in the database as MMMMMMMM.
Frequently asked questions
- What is CVE-2020-10554?
- An issue was discovered in Psyprax beforee 3.2.2. Passwords used to encrypt the data are stored in the database in an obfuscated format, which can be easily reverted. For example, the password AAAAAAAA is stored in the database as MMMMMMMM.
- How severe is CVE-2020-10554?
- CVE-2020-10554 has a CVSS 3.x base score of 7.5, rated high severity. It is exploitable over network with low attack complexity, requires no privileges and no user interaction. Impact on confidentiality is high, integrity none, and availability none.
- Is CVE-2020-10554 being actively exploited?
- It is not currently listed in CISA's KEV catalog. Its EPSS exploit-prediction score is 1% (51st percentile), an estimate of the probability of exploitation in the next 30 days.
- What products are affected by CVE-2020-10554?
- CVE-2020-10554 affects Psyprax. See the affected-products list for the exact vulnerable versions.
- How do I fix CVE-2020-10554?
- Review the linked vendor and NVD advisories for patched versions and mitigations, then upgrade or apply the recommended workaround. Given its high severity, prioritise patching exposed systems.
- When was CVE-2020-10554 published?
- CVE-2020-10554 was published on 2021-02-05 and last updated on 2026-06-17.
References
Affected products (1)
- cpe:2.3:a:psyprax:psyprax:*:*:*:*:*:*:*:*
More vulnerabilities in Psyprax
- CVE-2020-10552 — High (CVSS 8.1): An issue was discovered in Psyprax before 3.2.2. The Firebird database is accessible with the default user sysdba and…
- CVE-2020-10553 — Medium (CVSS 5.5): An issue was discovered in Psyprax before 3.2.2. The file %PROGRAMDATA%\Psyprax32\PPScreen.ini contains a hash for the…
Other CWE-326 (Inadequate Encryption Strength) vulnerabilities
- CVE-2026-44523 — Critical (CVSS 10.0): Note Mark is an open-source note-taking application. Prior to 0.19.4, no minimum length or entropy is enforced on the…
- CVE-2020-6966 — Critical (CVSS 10.0): In ApexPro Telemetry Server Versions 4.2 and prior, CARESCAPE Telemetry Server v4.2 & prior, Clinical Information…
- CVE-2014-9199 — Critical (CVSS 10.0): The Clorius Controls Java web client before 01.00.0009g allows remote attackers to discover credentials by sniffing the…
- CVE-2018-25272 — Critical (CVSS 9.8): ELBA5 5.8.0 contains a remote code execution vulnerability that allows attackers to obtain database credentials and…
- CVE-2025-12478 — Critical (CVSS 9.8): Non-Compliant TLS Configuration.This issue affects BLU-IC2: through 1.19.5; BLU-IC4: through 1.19.5 .
- CVE-2022-24116 — Critical (CVSS 9.8): Certain General Electric Renewable Energy products have inadequate encryption strength. This affects iNET and iNET II…
Browse all CWE-326 (Inadequate Encryption Strength) vulnerabilities →